Literature DB >> 25825214

Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone.

Chris Stockmann1, Christopher A Reilly2, Bernhard Fassl3, Roger Gaedigk4, Flory Nkoy3, Bryan Stone3, Jessica K Roberts3, Derek A Uchida3, J Steven Leeder4, Catherine M T Sherwin3, Michael G Spigarelli3, Garold S Yost2, Robert M Ward5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25825214      PMCID： PMC4530077          DOI： 10.1016/j.jaci.2015.02.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.

Authors:  P Kuehl; J Zhang; Y Lin; J Lamba; M Assem; J Schuetz; P B Watkins; A Daly; S A Wrighton; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; R Venkataramanan; S Strom; K Thummel; M S Boguski; E Schuetz
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  A step toward personalized asthma treatment.

Authors:  Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

3.  Ethnic differences in the distribution of CYP3A5 gene polymorphisms.

Authors:  S Quaranta; D Chevalier; D Allorge; J M Lo-Guidice; F Migot-Nabias; A Kenani; M Imbenotte; F Broly; B Lacarelle; M Lhermitte
Journal:  Xenobiotica       Date:  2006-12       Impact factor: 1.908

4.  Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.

Authors:  Chris Stockmann; Bernhard Fassl; Roger Gaedigk; Flory Nkoy; Derek A Uchida; Steven Monson; Christopher A Reilly; J Steven Leeder; Garold S Yost; Robert M Ward
Journal:  J Pediatr       Date:  2013-01-03       Impact factor: 4.406

5.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.

Authors:  D Wang; Y Guo; S A Wrighton; G E Cooke; W Sadee
Journal:  Pharmacogenomics J       Date:  2010-04-13       Impact factor: 3.550

6.  Gametic disequilibrium measures: proceed with caution.

Authors:  P W Hedrick
Journal:  Genetics       Date:  1987-10       Impact factor: 4.562

7.  Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.

Authors:  Kelan G Tantisira; Jessica Lasky-Su; Michishige Harada; Amy Murphy; Augusto A Litonjua; Blanca E Himes; Christoph Lange; Ross Lazarus; Jody Sylvia; Barbara Klanderman; Qing Ling Duan; Weiliang Qiu; Tomomitsu Hirota; Fernando D Martinez; David Mauger; Christine Sorkness; Stanley Szefler; Stephen C Lazarus; Robert F Lemanske; Stephen P Peters; John J Lima; Yusuke Nakamura; Mayumi Tamari; Scott T Weiss
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

8.  Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

Authors:  Stanley J Szefler; Brenda R Phillips; Fernando D Martinez; Vernon M Chinchilli; Robert F Lemanske; Robert C Strunk; Robert S Zeiger; Gary Larsen; Joseph D Spahn; Leonard B Bacharier; Gordon R Bloomberg; Theresa W Guilbert; Gregory Heldt; Wayne J Morgan; Mark H Moss; Christine A Sorkness; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

9.  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

10.  Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes.

Authors:  Jessica K Roberts; Chad D Moore; Robert M Ward; Garold S Yost; Christopher A Reilly
Journal:  J Pharmacol Exp Ther       Date:  2013-03-19       Impact factor: 4.030
  10 in total
  3 in total

Review 1.  Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.

Authors:  Gaëlle Magliocco; Frédérique Rodieux; Jules Desmeules; Caroline Flora Samer; Youssef Daali
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

2.  Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma.

Authors:  Cassandra E Deering-Rice; Chris Stockmann; Erin G Romero; Zhenyu Lu; Darien Shapiro; Bryan L Stone; Bernhard Fassl; Flory Nkoy; Derek A Uchida; Robert M Ward; John M Veranth; Christopher A Reilly
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

3.  Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study.

Authors:  Yuan-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.